In line with the data obtained from metastasis studies in mice, loss of IRF7-associated gene signature in primary tumors of breast cancer patients predicted an increased risk of bone metastasis and also additional studies suggest a suppressive role for type I IFN signaling on breast cancer progression (25). The gene discussed is IRF7; the disease is breast cancer.